Myopia

Contact lenses can be beneficial for children, even when not medically necessary, explains Jennifer Fogt, OD, FAAO, FSLS.

The CHAMP phase 3 study shows strong safety and efficacy of NVK002 for the treatment of myopia.

Vitto Mena, Jr., OD, MS, shares highlights from his discussion titled, "Contact lenses for kids: concepts and methods for contemporary care," which he co-presented during the 2022 American Academy of Optometry meeting.

When interpreting study findings, take into consideration the similarity and the differences between the subjects recruited for the study versus the patient population each practitioner serves.

Evolution of vision correction procedures, diagnostics paves way for collaborative care.

World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.

In honor of World Sight Day, optometrists and ophthalmologists reflect on what today means to them.

Johnson & Johnson Vision receives FDA-approval of lens parameter expansion for their ACUVUE Abiliti Overnight Therapeutic Lenses for Myopia Management.

Clinical pilot study evaluates effect after 1 month of wear.

Alexis Malkin, OD, FAAO, highlights her Vision Expo West 2022 presentation titled, "Expand your practice: how to integrate low vision into everyday patient care and improve outcomes."

Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia

Valerie M. Kattouf, OD, shares key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."

Low prediction errors from 2 evaluated formulas shows promise for accurate prediction of IOL formulas in high myopic patients.

Clinical pilot study evaluates effect after 1 month of wear.

Researchers in Tokyo found that nearly 50% of preschoolers are myopic, indicating that the disease has reached epidemic proportions.

Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.

Healthy digital media habits make a healthy child.

Studies conducted with Orbis International conclude positive mental health and academic improvements of children provided appropriate eye care and glasses, filling important research gaps and providing essential guidance for future interventions and research.

A recent study by Orbis International reports that children with myopia experienced significantly higher levels of depression and anxiety than their peers without vision impairment.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, shares highlights from his AOA 2022 presentation, "Myopia Management: One Child at a Time (Translating theory into practice)."

Correcting refractive errors in infants and toddlers differs from that in adults. Ida Chung, OD, MS, FCOVD, FAAO, walks optometrists through the pearls and pitfalls of prescribing for this patient population.

The amount of light effused by these round-shaped eyeglass frames are designed to match the exact wavelength of sunlight a user would be exposed to outside.

Interim data findings on spectacles using SightGlass Vision Diffusion Optics Technology were presented at ARVO 2022.

Set for May 23-28, the global initiative aims to bring attention to the global epidemic of myopia cases in children.

Duo commits to a second year working together after a year of achievements in addressing myopia management among ECPs.

Sunlight in the classroom can be a protective measure against the development of myopia, researchers have found.

US commercialization of EVO will begin immediately in select cities across the country.

Some optometrists are reluctant to incorporate myopia control into practice. With global cases on the rise, the time to act is now.

Check out this week's cartoon!

Pipeline treatments for presbyopia, myopia, and demodex are expanding rapidly